 |
0 Diseases |  |
77 Trials |
|
77 Trials |  |
6639 News |  |
| «12...73747576777879808182838485» |
- || furosemide / Generic mfg.
New P3 trial: FST-IFTA: Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease (clinicaltrials.gov) - Apr 16, 2015
P3, N=100, Recruiting, Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
- || furosemide / Generic mfg.
Trial primary completion date: ROPA-DOP: Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - Apr 15, 2015
P4, N=120, Recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Jun 2015 --> Jun 2016
- | Actimab-A (lintuzumab-Ac225) / Actinium
Enrollment closed: Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients (clinicaltrials.gov) - Apr 6, 2015
P1/2, N=24, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Active, not recruiting
- furosemide / Generic mfg.
Enrollment open: Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes (clinicaltrials.gov) - Mar 29, 2015
P=N/A, N=48, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Enrollment closed, Trial primary completion date: DIUPRE: Diuretics for Postpartum High Blood Pressure in Preeclampsia (clinicaltrials.gov) - Mar 25, 2015
P4, N=120, Active, not recruiting, Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014
- Henletor (torsemide) / Orchid
Enrollment change, Trial termination, Trial primary completion date: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Feb 19, 2015
P1, N=12, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014 N=26 --> 12 | Recruiting --> Terminated | Trial primary completion date: May 2015 --> Dec 2014; Lack of efficacy
- |||| CLS003 / Maruho
Enrollment open, P2 data: A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. (clinicaltrials.gov) - Feb 6, 2015
P2, N=80, Recruiting, Sponsor: Cutanea Life Sciences, Inc.
N=26 --> 12 | Recruiting --> Terminated | Trial primary completion date: May 2015 --> Dec 2014; Lack of efficacy Not yet recruiting --> Recruiting
- ||||| New P4 trial, Surgery: Early Diuresis Following Colorectal Surgery (clinicaltrials.gov) - Jan 30, 2015
P4, N=286, Recruiting, Sponsor: Mayo Clinic
- furosemide / Generic mfg.
New P1/2 trial: FUROPHARM-HF: Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration (clinicaltrials.gov) - Jan 30, 2015
P1/2, N=10, Recruiting, Sponsor: scPharmaceuticals, Inc.
- || furosemide / Generic mfg.
New P3 trial: IRIHS-REA: Impact of Rational Control of Fluid Balance in the Intensive Care Unit (clinicaltrials.gov) - Jan 26, 2015
P3, N=172, Not yet recruiting, Sponsor: Nantes University Hospital
- | metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
Trial completion: Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin (clinicaltrials.gov) - Jan 26, 2015
P1, N=24, Completed, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- furosemide / Generic mfg.
Trial primary completion date: AVOID-HF: Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment (clinicaltrials.gov) - Jan 15, 2015
P=N/A, N=224, Terminated, Sponsor: Gambro Renal Products, Inc.
Active, not recruiting --> Completed Trial primary completion date: May 2016 --> Jul 2014
- furosemide / Generic mfg.
Enrollment change, Trial primary completion date: The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury (clinicaltrials.gov) - Jan 15, 2015
P=N/A, N=200, Recruiting, Sponsor: University of Chicago
Trial primary completion date: May 2016 --> Jul 2014 N=150 --> 200 | Trial primary completion date: Dec 2014 --> Dec 2015
- ||||| CLS003 / Maruho
New P2 trial, P2 data: A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. (clinicaltrials.gov) - Jan 7, 2015
P2, N=80, Not yet recruiting, Sponsor: Cutanea Life Sciences, Inc.
- furosemide / Generic mfg., spironolactone / Generic mfg.
Trial primary completion date: DESALT Study: Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (clinicaltrials.gov) - Jan 2, 2015
P4, N=54, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
N=150 --> 200 | Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Jul 2014 --> Feb 2015
- furosemide / Generic mfg.
New P2/3 trial: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure (clinicaltrials.gov) - Jan 2, 2015
P2/3, N=16, Not yet recruiting, Sponsor: scPharmaceuticals, Inc.
- ||||| furosemide / Generic mfg.
New P2 trial: DRAFFT: Delayed Renal Allograft Function and Furosemide Treatment (clinicaltrials.gov) - Dec 10, 2014
P2, N=120, Not yet recruiting, Sponsor: Loma Linda University
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial primary completion date: Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function (clinicaltrials.gov) - Dec 5, 2014
P4, N=36, Recruiting, Sponsor: Corporacion Parc Tauli
Trial primary completion date: Jul 2014 --> Feb 2015 Trial primary completion date: Nov 2014 --> Mar 2015
- furosemide / Generic mfg.
Enrollment closed: ANSWER: Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis (clinicaltrials.gov) - Dec 5, 2014
P4, N=440, Active, not recruiting, Sponsor: University of Bologna
Trial primary completion date: Nov 2014 --> Mar 2015 Recruiting --> Active, not recruiting
- metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
Enrollment closed: Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin (clinicaltrials.gov) - Nov 20, 2014
P1, N=24, Active, not recruiting, Sponsor: Boehringer Ingelheim
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- furosemide / Generic mfg.
Trial primary completion date: ANSWER: Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis (clinicaltrials.gov) - Oct 24, 2014
P4, N=440, Recruiting, Sponsor: University of Bologna
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2013 --> Nov 2014
- || furosemide / Generic mfg.
New P3 trial: DiPER: Diuretic Versus Placebo in Pulmonary Embolism (clinicaltrials.gov) - Oct 20, 2014
P3, N=270, Not yet recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
Enrollment open: Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin (clinicaltrials.gov) - Oct 11, 2014
P1, N=24, Recruiting, Sponsor: Boehringer Ingelheim
Trial primary completion date: Jun 2013 --> Nov 2014 Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: FADE: Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial (clinicaltrials.gov) - Sep 16, 2014
P3, N=50, Recruiting, Sponsor: Hamilton Health Sciences Corporation
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Sep 2014 | Trial primary completion date: Jan 2015 --> Jul 2015
- | metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
New P1 trial: Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin (clinicaltrials.gov) - Sep 5, 2014
P1, N=24, Not yet recruiting, Sponsor: Boehringer Ingelheim
- furosemide / Generic mfg.
Enrollment change: Aerosol Inhalation Treatment for Dyspnea (clinicaltrials.gov) - Aug 8, 2014
P1/2, N=32, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Sep 2014 | Trial primary completion date: Jan 2015 --> Jul 2015 N=24 --> 32
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial primary completion date: Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function (clinicaltrials.gov) - Aug 1, 2014
P4, N=36, Recruiting, Sponsor: Corporacion Parc Tauli
N=24 --> 32 Trial primary completion date: Jul 2014 --> Nov 2014
- furosemide / Generic mfg.
Trial primary completion date: Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure (clinicaltrials.gov) - Jul 28, 2014
P4, N=160, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Jul 2014 --> Nov 2014 Trial primary completion date: Jul 2014 --> Jul 2015
- furosemide / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: SPARK: Furosemide in Early Acute Kidney Injury (clinicaltrials.gov) - Jul 24, 2014
P2/3, N=72, Terminated, Sponsor: University of Alberta
Trial primary completion date: Jul 2014 --> Jul 2015 N=216 --> 72 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Jul 2014; Feasibility of target enrollment within the context of available funding resources.
- | ethacrynic acid / Generic mfg., furosemide / Generic mfg.
Trial completion, Enrollment change, Surgery: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease (clinicaltrials.gov) - Jul 24, 2014
P3, N=74, Completed, Sponsor: Bambino Gesù Hospital and Research Institute
N=216 --> 72 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Jul 2014; Feasibility of target enrollment within the context of available funding resources. Recruiting --> Completed | N=106 --> 74
- Henletor (torsemide) / Orchid
Trial primary completion date: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Jul 21, 2014
P1, N=26, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | N=106 --> 74 Trial primary completion date: Dec 2015 --> May 2015
- | tolvaptan / Generic mfg., furosemide / Generic mfg.
New P4 trial: AQUA-AHF: Aquaresis Utility for Hyponatremic Acute Heart Failure Study (clinicaltrials.gov) - Jul 8, 2014
P4, N=50, Not yet recruiting, Sponsor: University of Southern California
- furosemide / Generic mfg.
Trial primary completion date: Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass (clinicaltrials.gov) - Jul 1, 2014
P=N/A, N=64, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
Trial primary completion date: Dec 2015 --> May 2015 Trial primary completion date: Nov 2013 --> Nov 2014
- || tolvaptan / Generic mfg., midodrine hydrochloride / Generic mfg.
New P2/3 trial: Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites (clinicaltrials.gov) - Jun 27, 2014
P2/3, N=60, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- | tolvaptan / Generic mfg., midodrine hydrochloride / Generic mfg.
Enrollment open: Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites (clinicaltrials.gov) - Jun 27, 2014
P2/3, N=60, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: Nov 2013 --> Nov 2014 Not yet recruiting --> Recruiting
- | furosemide / Generic mfg.
New P4 trial: DIUPRE: Diuretics for Postpartum High Blood Pressure in Preeclampsia (clinicaltrials.gov) - Jun 13, 2014
P4, N=120, Recruiting, Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
- Henletor (torsemide) / Orchid
Enrollment open: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Jun 13, 2014
P1, N=26, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Trial suspension: REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure (clinicaltrials.gov) - May 18, 2014
P4, N=186, Suspended, Sponsor: Niguarda Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Suspended
- furosemide / Generic mfg.
Trial completion date: REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure (clinicaltrials.gov) - May 18, 2014
P4, N=186, Suspended, Sponsor: Niguarda Hospital
Active, not recruiting --> Suspended Trial completion date: Dec 2013 --> May 2014
- furosemide / Generic mfg.
Enrollment open: ROPA-DOP: Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - Apr 16, 2014
P4, N=120, Recruiting, Sponsor: Johns Hopkins University
Trial completion date: Dec 2013 --> May 2014 Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Trial termination: AVOID-HF: Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment (clinicaltrials.gov) - Apr 13, 2014
P=N/A, N=224, Terminated, Sponsor: Gambro Renal Products, Inc.
Recruiting --> Terminated; Closed due to patient recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.
- furosemide / Generic mfg.
Enrollment change: AVOID-HF: Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment (clinicaltrials.gov) - Apr 13, 2014
P=N/A, N=224, Terminated, Sponsor: Gambro Renal Products, Inc.
No interim analyses were completed; study closure was not related to any concerns about safety or futility. N=810 --> 224
- Henletor (torsemide) / Orchid
Trial initiation date: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Apr 6, 2014
P1, N=26, Not yet recruiting, Sponsor: Merck Sharp & Dohme Corp.
N=810 --> 224 Initiation date: Jan 2014 --> May 2014
- Henletor (torsemide) / Orchid
Enrollment change: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Apr 6, 2014
P1, N=26, Not yet recruiting, Sponsor: Merck Sharp & Dohme Corp.
Initiation date: Jan 2014 --> May 2014 N=18 --> 26
- furosemide / Generic mfg., bumetanide / Generic mfg.
Trial withdrawal: Bumetanide Versus Furosemide in Heart Failure (clinicaltrials.gov) - Mar 25, 2014
P3, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
N=18 --> 26 Not yet recruiting --> Withdrawn
- furosemide / Generic mfg., bumetanide / Generic mfg.
Enrollment change: Bumetanide Versus Furosemide in Heart Failure (clinicaltrials.gov) - Mar 25, 2014
P3, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
Not yet recruiting --> Withdrawn N=15 --> 0
- furosemide / Generic mfg., spironolactone / Generic mfg.
Enrollment open: DESALT Study: Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (clinicaltrials.gov) - Mar 18, 2014
P4, N=54, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
N=15 --> 0 Not yet recruiting --> Recruiting
- |||| furosemide / Generic mfg.
Trial completion: Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure (clinicaltrials.gov) - Feb 22, 2014
P4, N=198, Completed, Sponsor: University of Calgary
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- furosemide / Generic mfg.
Clinical: Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=270, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
- furosemide / Generic mfg.
Enrollment change: AKI: Protocol to Assess the Severity of Acute Kidney Injury (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=44, Completed, Sponsor: George Washington University
No longer recruiting --> Completed N=150 --> 44